News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

American Hospital Resources, Inc. Issues Update



10/19/2005 5:10:38 PM

HONOLULU, March 31 /PRNewswire-FirstCall/ -- American Hospital Resources, Inc. (OTC Bulletin Board: AMHR; Berlin (WKN) 913541) recently announced that the board of directors has retained Judah Marvin Feigenbaum's services to spearhead the acquisition efforts of the Company. Mr. Feigenbaum's 30 years of experience in the healthcare industry, with a special focus on acquisitions and consolidations, make him the perfect agent to direct the activities of the Company toward achieving it's goals in the Institutional Pharmaceutical Marketplace. In order to get the most efficient use of his relationships and experience, Mark Buck will retain the position of CEO until such time as the initial rollup is complete. It has been determined that Mr. Feigenbaum can be more effective in structuring acquisitions without immediately accepting the responsibilities of CEO.

Mr. Feigenbaum said, "Given the number of potential acquisitions requiring due diligence, both the Board and I feel that the day to day responsibilities of CEO would be a distraction from my primary mission. My primary responsibility to AMHR is to pursue these opportunities."

Additionally, the Company is scheduling presentations to the European investment community. As a result of our listing on the Berlin Stock Exchange, AMHR has been invited to speak to more than a dozen brokerage and analyst groups in Munich, Frankfurt, Dusseldorf, Hamburg and Berlin. It is anticipated that these presentations will take place during the second quarter of this year.

American Hospital Resources, Inc. anticipates acquiring and consolidating groups of Institutional Pharmacies. AMHR plans to acquire and consolidate pharmacy operations in several regions of the country with a plan to gain labor efficiencies as well as increase its pharmaceutical buying power and enhance its pricing and purchasing terms with the pharmaceutical supply houses.

Except for historical information contained herein, the matters discussed in this news release are forward-looking statements that involve risk and uncertainties, including but not limited to economic, competitive, governmental, political and technological factors affecting the Company's potential revenues, operations, markets, products and prices and other factors discussed in the Company's various filings with the Securities and Exchange Commission.

For more information please contact Investor Relations for American Hospital Resources, Inc., +1-888-918-8847, invrelations@amhrinc.com.

American Hospital Resources, Inc.

CONTACT: Investor Relations for American Hospital Resources, Inc.,+1-888-918-8847, invrelations@amhrinc.com


Read at BioSpace.com


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES